Costs of HIV⁄AIDS outpatient services delivered through Zambian public health facilities
Date
2011
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Tropical Medicine and International Health
Abstract
objective To present evidence on unit and total costs of outpatient HIV ⁄ AIDS services in ZPCT supported facilities in Zambia; specifically, to measure unit costs of selected outpatient HIV ⁄ AIDS
services, and to estimate total annual costs of antiretroviral therapy (ART) and prevention of mother-to child transmission (PMTCT) in Zambia.
methods Cost data from 2008 were collected in 12 ZPCT-supported facilities (hospitals and health
centres) in four provinces. Costs of all resources used to produce ART, PMTCT and CT visits were
included, using the perspective of the provider. All shared costs were distributed to clinic visits using
appropriate allocation variables. Estimates of annual costs of HIV ⁄ AIDS services were made using
ZPCT and Ministry of Health data on numbers of persons receiving services in 2009.
results Unit costs of visits were driven by costs of drugs, laboratory tests and clinical labour, while
variability in visit costs across facilities was explained mainly by differences in utilization. First-year
costs of ART per client ranged from US$278 to US$523 depending on drug regimen and facility type;
costs of a complete course of antenatal care (ANC) including PMTCT were approximately US$114.
Annual costs of ART provided in ZPCT-supported facilities were estimated at US$14.7–$40.1 million
depending on regimen, and annual costs of antenatal care including PMTCT were estimated at
US$16 million. In Zambia as a whole, the respective estimates were US$41.0–114.2 million for ART
and US$57.7 million for ANC including PMTCT.
conclusions Consistent with the literature, total costs of services were dominated by drugs, labora tory tests and clinical labour. For each visit type, variability across facilities in total costs and cost
components suggests that some potential exists to reduce costs through greater harmonization of care
protocols and more intensive use of fixed resources. Improving facility-level information on the costs of
resources used to produce services should be emphasized as an element of health systems strengthening.
Description
Research Article
Keywords
human immunodeficiency virus, costs and cost analysis, antiretroviral therapy, prevention of mother-to-child transmission, Zambia